Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Jairath

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Alimentary Pharmacology & Therapeutics|September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseasesK Papamichael, T Van Stappen, V Jairath, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2018
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's diseaseC Ma, S J Dutton, L E Cipriano, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2017
Review article: dose optimisation of infliximab for acute severe ulcerative colitisP Hindryckx, G Novak, N Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Alimentary Pharmacology & Therapeutics|December 23, 2017
HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel diseaseA Wilson, L E Jansen, R V Rose, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2017
The development of a magnetic resonance imaging index for fistulising Crohn's diseaseM A Samaan, C A J Puylaert, B G Levesque, et al.
BMJ Open|May 1, 2015
Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trialH E Campbell, E A Stokes, D Bargo, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2017
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitisG R D'Haens, W J Sandborn, G Zou, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2018
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's diseaseF Rieder, D Bettenworth, C Ma, et al.
Alimentary Pharmacology & Therapeutics|February 21, 2018
Reliability of histologic assessment in patients with eosinophilic oesophagitisM J Warners, C A Ambarus, A J Bredenoord, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Alimentary Pharmacology & Therapeutics|September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseasesK Papamichael, T Van Stappen, V Jairath, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2018
Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's diseaseC Ma, S J Dutton, L E Cipriano, et al.
Alimentary Pharmacology & Therapeutics|January 12, 2017
Review article: dose optimisation of infliximab for acute severe ulcerative colitisP Hindryckx, G Novak, N Vande Casteele, et al.
Alimentary Pharmacology & Therapeutics|April 27, 2018
Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitisC Ma, L Guizzetti, R Panaccione, et al.
Alimentary Pharmacology & Therapeutics|December 23, 2017
HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel diseaseA Wilson, L E Jansen, R V Rose, et al.
Alimentary Pharmacology & Therapeutics|June 28, 2017
The development of a magnetic resonance imaging index for fistulising Crohn's diseaseM A Samaan, C A J Puylaert, B G Levesque, et al.
BMJ Open|May 1, 2015
Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trialH E Campbell, E A Stokes, D Bargo, et al.
Alimentary Pharmacology & Therapeutics|June 2, 2017
Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitisG R D'Haens, W J Sandborn, G Zou, et al.
Alimentary Pharmacology & Therapeutics|June 20, 2018
An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's diseaseF Rieder, D Bettenworth, C Ma, et al.
Alimentary Pharmacology & Therapeutics|February 21, 2018
Reliability of histologic assessment in patients with eosinophilic oesophagitisM J Warners, C A Ambarus, A J Bredenoord, et al.
Pageof 3